GlassScriptPhysician profile
Alexis Salva
NPI 1417411315
$1,754.71
in general payments reported to CMS, 2019-2025
16 companies · $381 in 2025
The $381 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $209 · 2022: $173 · 2023: $385 · 2024: $607 · 2025: $381.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,373.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,372.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $682.24 | 2021-2025 | Dexcom G6 Transmitter |
| Cequr Corporation | $331.04 | 2024 | Cequr Simplicity |
| Lilly USA, LLC | $175.75 | 2022-2025 | Mounjaro, Zepbound |
| Sanofi-Aventis U.S. LLC | $150.00 | 2023 | |
| Amgen INC. | $87.32 | 2025 | Evenity |
| Tandem Diabetes Care, INC. | $81.31 | 2021 | |
| Novo Nordisk INC | $51.27 | 2023-2025 | Ozempic, Rybelsus |
| Medtronic, INC. | $46.13 | 2022-2024 | Minimed 780g |
| Recordati_rare_diseases_inc. | $23.68 | 2023 | Signifor Lar, Isturisa |
| Esperion Therapeutics, INC. | $22.94 | 2025 | Nexletol |
| Abbott Laboratories | $22.41 | 2025 | Freestyle Libre 3 |
| Novartis Pharmaceuticals Corporation | $20.44 | 2024 | |
| Mannkind Corporation | $16.55 | 2025 | |
| Sequel Med Tech, LLC | $16.46 | 2025 | Twiist |
| Amphastar Pharmaceuticals, INC. | $14.03 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $13.14 | 2023 | Watchman Access System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexis Salva listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.